CoChat

Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial

Ngure, Kenneth, Ortblad, Katrina F, Mogere, Peter, Bardon, Ashley R, Thomas, Katherine K, Mangale, Dorothy, Kiptinness, Catherine, Gakuo, Stephen, Mbaire, Sarah, Nyokabi, Jacinta, Mugo, Nelly R, Baeten, Jared M · 2022 · The Lancet HIV
Cited by 49

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2352-3018(22)00126-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 24

  1. Venter, 2018, Pre-exposure prophylaxis: the delivery challenge, Front Public Health, 6, 188, 10.3389/fpubh.2018.00188 · doi:10.3389/fpubh.2018.00188
  2. Mack, 2014, Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders, BMC Health Serv Res, 14, 231, 10.1186/1472-6963-14-231 · DOI
  3. Patel, 2016, “Since both of us are using antiretrovirals, we have been supportive to each other”: facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya, J Int AIDS Soc, 19, 10.7448/IAS.19.1.21134 · DOI
  4. Bigogo, 2010, Health-seeking patterns among participants of population-based morbidity surveillance in rural western Kenya: implications for calculating disease rates, Int J Infect Dis, 14, e967, 10.1016/j.ijid.2010.05.016 · DOI
  5. Ngure, 2017, Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya, J Int AIDS Soc, 20, 10.7448/IAS.20.1.21234 · DOI · Paper page
  6. Ortblad, 2018, Acceptability of HIV self-testing to support pre-exposure prophylaxis among female sex workers in Uganda and Zambia: results from two randomized controlled trials, BMC Infect Dis, 18, 503, 10.1186/s12879-018-3415-z · DOI
  7. Wanga, 2020, Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya, J Int AIDS Soc, 23, 10.1002/jia2.25561 · doi:10.1002/jia2.25561
  8. Hector, 2018, Acceptability and performance of a directly assisted oral HIV self-testing intervention in adolescents in rural Mozambique, PLoS One, 13, 10.1371/journal.pone.0195391 · DOI · Paper page
  9. Dovel, 2020, Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial, Lancet Glob Health, 8, e276, 10.1016/S2214-109X(19)30534-0 · DOI · Paper page
  10. Thirumurthy, 2016, Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort study, Lancet HIV, 3, e266, 10.1016/S2352-3018(16)00041-2 · DOI · Paper page
  11. Masters, 2016, Promoting partner testing and couples testing through secondary distribution of HIV self-tests: a randomized clinical trial, PLoS Med, 13, 10.1371/journal.pmed.1002166 · DOI · Paper page
  12. Ortblad, 2019, HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya, Trials, 20, 396, 10.1186/s13063-019-3521-2 · DOI
  13. Anderson, 2017, Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy, Antimicrob Agents Chemother, 62, e01710
  14. Reed, 2021, HIV PrEP is more than ART-lite: longitudinal study of real-world PrEP services data identifies missing measures meaningful to HIV prevention programming, J Int AIDS Soc, 24, 10.1002/jia2.25827 · DOI
  15. Althunian, 2017, Defining the noninferiority margin and analysing noninferiority: an overview, Br J Clin Pharmacol, 83, 1636, 10.1111/bcp.13280 · DOI · Paper page
  16. Salow, 2017, Comparing mail-in self-collected specimens sent via United States Postal Service versus clinic-collected specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in extra-genital sites, PLoS One, 12, 10.1371/journal.pone.0189515 · DOI
  17. Van Damme, 2012, Preexposure prophylaxis for HIV infection among African women, N Engl J Med, 367, 411, 10.1056/NEJMoa1202614 · DOI · Paper page
  18. Heffron, 2018, Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa, Gates Open Res, 1, 3, 10.12688/gatesopenres.12752.2 · DOI
  19. Wachinger, 2021, “But I gathered my courage”: HIV self-testing as a pathway of empowerment among Ugandan female sex workers, Qual Health Res, 31, 443, 10.1177/1049732320978392 · DOI
  20. Jaspard, 2014, Finger-stick whole blood HIV-1/-2 home-use tests are more sensitive than oral fluid-based in-home HIV tests, PLoS One, 9, 10.1371/journal.pone.0101148 · DOI
  21. Parikh, 2016, Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?, Curr Opin HIV AIDS, 11, 49, 10.1097/COH.0000000000000209 · DOI
  22. Cucinotta, 2020, WHO declares COVID-19 a pandemic, Acta Biomed, 91, 157
  23. Pampati, 2020, Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South, medRxiv
  24. Hoagland, 2020, Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil, Braz J Infect Dis, 24, 360, 10.1016/j.bjid.2020.05.004 · DOI

Metadata

Authors
Ngure, K., Ortblad, K. F., Mogere, P., Bardon, A. R., Thomas, K. K., Mangale, D., Kiptinness, C., Gakuo, S., Mbaire, S., Nyokabi, J., Mugo, N. R., & Baeten, J. M.
Venue
The Lancet HIV
Publisher
Elsevier BV
Published
2022-07
Volume
9
Issue
7
Pages
e464-e473
ISSN
2352-3018
Cited by
49
References
3
Language
en
Funders
  • National Institute of Mental Health (K99 MH121166, R01 MH113572, R34 MH120106)
  • National Institute of Allergy and Infectious Diseases
  • National Center for Advancing Translational Sciences (TL1 TR002318)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial. https://app.cochat.ai/papers/10.1016/s2352-3018(22)00126-6
The paper
Ngure, K., Ortblad, K. F., Mogere, P., Bardon, A. R., Thomas, K. K., Mangale, D., Kiptinness, C., Gakuo, S., Mbaire, S., Nyokabi, J., Mugo, N. R., & Baeten, J. M. (2022). Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial. The Lancet HIV. https://doi.org/10.1016/s2352-3018(22)00126-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.